作者:Carine Aubry、A. James Wilson、Daniel Emmerson、Emma Murphy、Yu Yam Chan、Michael P. Dickens、Marcos D. García、Paul R. Jenkins、Sachin Mahale、Bhabatosh Chaudhuri
DOI:10.1016/j.bmc.2009.06.070
日期:2009.8
We present the design, synthesis and biological activity of a new series of substituted 3-(2-(1H-indol-1-yl)ethyl)-1H-indoles and 1,2-di(1H-indol-1-yl)alkanes as selective inhibitors of CDK4/cyclin D1. The compounds were designed to explore the relationship between the connection mode of the indolyl moieties and their CDK inhibitory activities. We found all the above-mentioned designed compounds to
我们目前的设计,合成和一个新的一系列取代的3-(2-(1的生物活性的ħ -吲哚-1-基)乙基)-1 ħ -indoles和1,2-二(1 ħ -吲哚-1-烷基)烷烃作为CDK4 /细胞周期蛋白D1的选择性抑制剂。设计这些化合物以探索吲哚基部分的连接模式与其CDK抑制活性之间的关系。与紧密相关的CDK2 / cyclin A相比,我们发现所有上述设计的化合物都是CDK4 / cyclin D1的选择性抑制剂,最佳化合物10m和13a的IC 50分别为39和37μm。